EUVIMEDEUVIMED entdecken
Crossref

IL ‐10 indirectly modulates functional activity of CD4 + CD28 null T‐lymphocytes through LFA ‐3 and HLA class II inhibition

Alejandra García-Torre iD, Eva Bueno-García, Marco A Moro-García, Rocío López-Martínez, Beatriz Rioseras, Beatriz Díaz-Molina, José Luis Lambert, Rebeca Alonso-Arias

Immunology · 2024

DOI: 10.1111/imm.13824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, 2024. Verfasst von Alejandra García-Torre und 7 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. Hauptthemen laut MEDLINE: Interleukin-10, CD28 Antigens, CD4-Positive T-Lymphocytes, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Gobierno del Principado de Asturias, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Expansion of CD4 + CD28 null T‐lymphocytes is common in chronic heart failure (CHF) patients. Its ability to produce high levels of proinflammatory cytokines is probably the key role of these cells in CHF. IL‐10 is a candidate for limiting CD4 + CD28 null T‐lymphocyte responses, whereas tumour necrosis factor (TNF) is the cytokine most closely involved in the loss of CD28 expression. Serum levels of TNF and IL‐10 were measured in 65 CHF patients (mean age, 65.2 ± 13.84 years). Patients with an IL‐10/TNF ratio ≥1 had significantly lower levels of CD4 + CD28 null T‐lymphocytes than those with a ratio

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-10CD28 AntigensCD4-Positive T-LymphocytesTumor Necrosis Factor-alphaHumansMaleFemaleMiddle AgedAgedHistocompatibility Antigens Class IIHeart FailureLymphocyte ActivationCell ProliferationLymphocyte Activation Gene 3 ProteinCells, CulturedIntercellular Adhesion Molecule-1HLA-DR AntigensMonocytes

Stichwörter der Autor:innen

T‐lymphocyte differentiationchronic heart failureimmunosenescence

Substanzen

Interleukin-10CD28 AntigensTumor Necrosis Factor-alphaHistocompatibility Antigens Class IILymphocyte Activation Gene 3 ProteinIL10 protein, humanIntercellular Adhesion Molecule-1HLA-DR Antigens

Autor:innen und Institutionen

  • Immunology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
  • Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Oviedo, Spain.
  • Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Section of Hemodynamics and Interventional Cardiology, Department of Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain.

ORCID-Profile: Alejandra García-Torre

Förderung

  • Gobierno del Principado de Asturias
  • Instituto de Salud Carlos III

Zitieren

APA

García-Torre, A., Bueno-García, E., Moro-García, M. A., López-Martínez, R., Rioseras, B., Díaz-Molina, B., Lambert, J. L., & Alonso-Arias, R. (2024). IL ‐10 indirectly modulates functional activity of CD4 + CD28 null T‐lymphocytes through LFA ‐3 and HLA class II inhibition. Immunology. https://doi.org/10.1111/imm.13824

Vancouver

García-Torre A, Bueno-García E, Moro-García MA, López-Martínez R, Rioseras B, Díaz-Molina B, et al. IL ‐10 indirectly modulates functional activity of CD4 + CD28 null T‐lymphocytes through LFA ‐3 and HLA class II inhibition. Immunology. 2024. doi:10.1111/imm.13824

BibTeX
@article{GarcaTorre2024,
  author = {García-Torre, Alejandra and Bueno-García, Eva and Moro-García, Marco A and López-Martínez, Rocío and Rioseras, Beatriz and Díaz-Molina, Beatriz and Lambert, José Luis and Alonso-Arias, Rebeca},
  title = {IL ‐10 indirectly modulates functional activity of CD4 + CD28 null T‐lymphocytes through LFA ‐3 and HLA class II inhibition},
  journal = {Immunology},
  year = {2024},
  doi = {10.1111/imm.13824}
}
Kostenlos starten →